2004
Clinical Trials in Sub-Saharan Africa and Established Standards of Care
Search citation statements
Paper Sections
Select...
32
2
0
0
Citation Types
0
3
0
0
Year Published
2004
2025
Publication Types
Select...
30
3
1
Relationship
0
34
Authors
Journals
Cited by 34 publications
(3 citation statements)
References 31 publications
0
3
0
0
Smart CitationsHow this paper cites the one you are viewing
“…Health care research in the developing world raises specific ethical questions driven by the different cultural, economic and socio-political factors [4][5][6]. Participants in internationally funded projects, usually with a very serious and grossly unequal burden of disease, receive the standard of health care available in the funding country, the moral principle of ''universal standard of care''.…”
mentioning
confidence: 99%
Smart CitationsHow this paper cites the one you are viewing
“…Health care research in the developing world raises specific ethical questions driven by the different cultural, economic and socio-political factors [4][5][6]. Participants in internationally funded projects, usually with a very serious and grossly unequal burden of disease, receive the standard of health care available in the funding country, the moral principle of ''universal standard of care''.…”
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…For example, RCTs conducted in sub-Saharan Africa to test treatments for tuberculosis tend to provide a high standard of tuberculosis care to control participants, while trials targeting AIDS usually do not provide state-of-the-art HIV care to control participants. (63)…”
Section: Introduction
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…4 With the commitment of the international community to increase HIV prevention and care, 5 HIV treatment has become increasingly accessible in Africa. 6 Due to the efforts of the Global Fund AIDS, TB, and Malaria, the U.S. President's emergency plan for AIDS Relief (PEPFAR), and numerous nongovernmental organizations and governmental programs, many developing countries are now scaling up access to antiretroviral therapy (ART). [7][8][9] Indeed, by the end of 2006, an estimated two million HIV-infected patients were receiving HAART in low-and middle-income countries.…”
Section: Introduction
mentioning
confidence: 99%
